In8Bio Inc (INAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,120 | 21,282 | 18,182 | 37,021 | 17,994 |
| TOTAL | $12,578 | $24,625 | $22,234 | $38,980 | $18,144 |
| Non-Current Assets | |||||
| PPE Net | 2,858 | 3,514 | 4,397 | 97 | 186 |
| Other Non-Current Assets | 5,508 | 5,570 | 6,408 | 3,146 | 2,580 |
| TOTAL | $8,366 | $9,084 | $10,805 | $3,243 | $2,766 |
| Total Assets | $20,944 | $33,709 | $33,039 | $42,223 | $20,910 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 174 |
| Accounts payable and accrued liabilities | 389 | 924 | 2,091 | 395 | 620 |
| Accrued Expenses | 1,047 | 2,955 | 2,342 | 1,235 | 1,778 |
| TOTAL | $3,083 | $5,393 | $5,822 | $2,256 | $2,572 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,088 | 2,854 | 3,674 | 1,515 | 0 |
| TOTAL | $3,383 | $3,379 | $4,485 | $1,784 | $17 |
| Total Liabilities | $6,466 | $8,772 | $10,307 | $4,040 | $2,589 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,706 | 1,441 | 830 | 626 | N/A |
| Common Shares | 7 | 4 | 3 | 2 | 1 |
| Retained earnings | -121,656 | -91,219 | -61,212 | -32,691 | -18,038 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 34,900 |
| TOTAL | $14,478 | $24,937 | $22,732 | $38,183 | $18,321 |
| Total Liabilities And Equity | $20,944 | $33,709 | $33,039 | $42,223 | $20,910 |